ZA976725B - Novel pentapeptides as antitumor agents - Google Patents

Novel pentapeptides as antitumor agents

Info

Publication number
ZA976725B
ZA976725B ZA976725A ZA976725A ZA976725B ZA 976725 B ZA976725 B ZA 976725B ZA 976725 A ZA976725 A ZA 976725A ZA 976725 A ZA976725 A ZA 976725A ZA 976725 B ZA976725 B ZA 976725B
Authority
ZA
South Africa
Prior art keywords
antitumor agents
pentapeptides
novel
novel pentapeptides
antitumor
Prior art date
Application number
ZA976725A
Other languages
English (en)
Inventor
Teresa Barlozzari
Andreas Haupt
Christian Griesinger
Bernd Janssen
Daniel Belik
Michael Boretzky
George R Pettit
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA976725B publication Critical patent/ZA976725B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA976725A 1996-07-30 1997-07-29 Novel pentapeptides as antitumor agents ZA976725B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/688,334 US5741892A (en) 1996-07-30 1996-07-30 Pentapeptides as antitumor agents

Publications (1)

Publication Number Publication Date
ZA976725B true ZA976725B (en) 1999-02-12

Family

ID=24764016

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA976725A ZA976725B (en) 1996-07-30 1997-07-29 Novel pentapeptides as antitumor agents

Country Status (7)

Country Link
US (1) US5741892A (xx)
EP (1) EP0915908A1 (xx)
JP (1) JP2000516923A (xx)
AU (1) AU3769297A (xx)
TW (1) TW472063B (xx)
WO (1) WO1998004581A1 (xx)
ZA (1) ZA976725B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100408909B1 (ko) * 1995-04-21 2004-04-29 데이꼬꾸 조끼 세이야꾸 가부시키가이샤 신규펩티드유도체
US6323315B1 (en) 1999-09-10 2001-11-27 Basf Aktiengesellschaft Dolastatin peptides
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US7256257B2 (en) 2001-04-30 2007-08-14 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
US6884869B2 (en) * 2001-04-30 2005-04-26 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
US7659241B2 (en) 2002-07-31 2010-02-09 Seattle Genetics, Inc. Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
BR122018071808B8 (pt) 2003-11-06 2020-06-30 Seattle Genetics Inc conjugado
US7853332B2 (en) * 2005-04-29 2010-12-14 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
CA2607940C (en) 2005-05-18 2009-12-15 Aegera Therapeutics Inc. Bir domain binding compounds
US8163792B2 (en) 2006-05-16 2012-04-24 Pharmascience Inc. IAP BIR domain binding compounds
AU2008276128B2 (en) 2007-07-16 2013-10-10 Genentech, Inc. Humanized anti-CD79b antibodies and immunoconjugates and methods of use
ES2579323T3 (es) 2007-07-16 2016-08-09 Genentech, Inc. Anticuerpos anti-CD79B e inmunoconjugados y métodos de uso
CL2009000062A1 (es) 2008-01-31 2010-05-14 Genentech Inc Anticuerpo humanizado anti cd79b; con modificaciones de cisterna libre; inmunoconjugado que contiene dicho anticuerpo y una droga; polinucleotido que codifica el anticuerpo; vector, celula huesped; composicion farmaceutica y uso de dicha composicion para tratar cancer, preferentemente linfomas.
SG10201501095WA (en) 2010-02-12 2015-04-29 Pharmascience Inc Iap bir domain binding compounds
WO2014080251A1 (en) 2012-11-24 2014-05-30 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
ES2960619T3 (es) 2014-02-28 2024-03-05 Hangzhou Dac Biotech Co Ltd Enlazadores cargados y sus usos para la conjugación
EP3689910A3 (en) 2014-09-23 2020-12-02 F. Hoffmann-La Roche AG Method of using anti-cd79b immunoconjugates
CA2991973C (en) 2015-07-12 2021-12-07 Suzhou M-Conj Biotech Co., Ltd. Bridge linkers for conjugation of a cell-binding molecule
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
CN110099682B (zh) 2016-11-14 2023-03-31 杭州多禧生物科技有限公司 偶联连接体，含有此连接体的细胞结合分子-药物偶联物及其制备和应用
WO2022190263A1 (ja) * 2021-03-10 2022-09-15 日本電信電話株式会社 情報処理装置、分析方法およびプログラム
MX2024002571A (es) 2021-09-03 2024-03-20 Toray Industries Composicion farmaceutica para tratamiento y/o prevencion de cancer.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
DK0934950T3 (da) * 1991-08-09 2002-07-29 Teikoku Hormone Mfg Co Ltd Tetrapeptidderivat
CZ292612B6 (cs) * 1992-05-20 2003-11-12 Abbott Gmbh & Co. Kg Peptid s protirakovinnou aktivitou, jeho použití a farmaceutický prostředek s obsahem takového peptidu
HUT72067A (en) * 1992-12-16 1996-03-28 Basf Ag Dolostatin analog
US5530097A (en) * 1994-08-01 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory peptide amides
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
US5663149A (en) * 1994-12-13 1997-09-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides

Also Published As

Publication number Publication date
TW472063B (en) 2002-01-11
JP2000516923A (ja) 2000-12-19
EP0915908A1 (en) 1999-05-19
AU3769297A (en) 1998-02-20
US5741892A (en) 1998-04-21
WO1998004581A1 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
EP0914330A4 (en) NEW TYPE COMPOUNDS
EP0961618A4 (en) NEW COMPOUNDS
ZA976725B (en) Novel pentapeptides as antitumor agents
EP0904104A4 (en) NEW CONNECTIONS
GB9601067D0 (en) Novel compounds
SG60040A1 (en) Novel heterroaryl-oxazolidinones
EP0904105A4 (en) NEW COMPOUNDS
AP9901465A0 (en) Illudin analogs useful as antitumor agents
ZA976724B (en) Novel tetrapeptides as antitumor agents
EP0895545A4 (en) A NEW PROTEIN, TRAF 6
GB9600955D0 (en) Novel compounds
AP9701037A0 (en) Novel compounds
GB9601041D0 (en) Novel compounds
GB9604045D0 (en) Novel compounds
GB9601069D0 (en) Novel compounds
EP0954525A4 (en) NEW CONNECTIONS
GB2310039B (en) Turbulence-noise cancelling means
PL328019A1 (en) Novel phenantidines
GB9601068D0 (en) Novel compounds
EP0907377A4 (en) NEW CONNECTIONS
GB9601099D0 (en) Novel compounds
GB9601066D0 (en) Novel compounds
GB9608813D0 (en) Pyridinyl-2-cyclopenten-1-ones as selctive cyclooxygenase-2-inhibitors
GB9601271D0 (en) Novel uses
AU127914S (en) Z bracket